Genomic and Transcriptomic Alterations Associated with STAT3 Activation in Head and Neck Cancer.

by Noah D Peyser, Kelsey Pendleton, William E Gooding, Vivian W Y Lui, Daniel E Johnson, Jennifer R Grandis
Published 2016-01-01

Gastrin-Releasing Peptide Receptor Mediates Activation of the Epidermal Growth Factor Receptor in Lung Cancer Cells

by Sufi Mary Thomas, Jennifer Rubin Grandis, Abbey L. Wentzel, William E. Gooding, Vivian Wai Yan Lui, Jill M. Siegfried
Published 2005-04-01

Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT

by Marie-Nicole Theodoraki, Saigopalakrishna Yerneni, William E. Gooding, James Ohr, David A. Clump, Julie E. Bauman, Robert L. Ferris, Theresa L. Whiteside
Published 2019-07-01

Inhibition of c-Met as a Therapeutic Strategy for Esophageal Adenocarcinoma

by Gregory A. Watson, Xinglu Zhang, Michael T. Stang, Ryan M. Levy, Pierre E. Queiroz de Oliveira, William E. Gooding, James G. Christensen, Steven J. Hughes
Published 2006-11-01

Ad-IRF-1 Induces Apoptosis in Esophageal Adenocarcinoma

by Gregory A. Watson, Pierre E. Queiroz de Oliveira, Michael T. Stang, Michaele J. Armstrong, William E. Gooding, Shih-Fan Kuan, John H. Yim, Steven J. Hughes
Published 2006-01-01

Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Cancer

by Julie E. Bauman, James Ohr, William E. Gooding, Robert L. Ferris, Umamaheswar Duvvuri, Seungwon Kim, Jonas T. Johnson, Adam C. Soloff, Gerald Wallweber, John Winslow, Autumn Gaither-Davis, Jennifer R. Grandis, Laura P. Stabile
Published 2020-06-01